View of Financial Performance Evaluation of Pharmaceutical Companies in Southeast Asia: The Influence of Cash Conversion Cycle, Sales Growth and Firm Size During the COVID-19 Pandemic

Return to Article Details Financial Performance Evaluation of Pharmaceutical Companies in Southeast Asia: The Influence of Cash Conversion Cycle, Sales Growth and Firm Size During the COVID-19 Pandemic Download Download PDF